Results 61 to 70 of about 501,137 (299)

Dosage-response profiles of all predictor genes.

open access: yes, 2023
We computed the dosage-response profiles for all predictor genes in 200 genetic backgrounds by individually tuning the corresponding dosage from g = 0 to g = 1 and computing the growth rate with FBA. Observe that i) all top predictors (with β > 0.01) are
Alvar A. Lavin (17373676)   +2 more
core   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Conventional radiotherapy of localized right side breast cancer after radical mastectomy: development of innovative “field in field” technique

open access: yesJournal of Health Sciences, 2011
Introduction: The aim of this paper is to study the distribution of the therapy dosage applied by a modified conventional “field in field” technique and compare it to the distribution of the dosage applied by the standard conventional technique. Methods:
Goran Marošević   +4 more
doaj   +1 more source

Palliative chemotherapy followed by consolidation radiotherapy in patients with advanced and metastatic non-small cell lung cancer not suitable for radical treatment [PDF]

open access: yesArchive of Oncology, 2012
Background: This is a retrospective study to assess the effectiveness of consolidation radiotherapy (CRT) following palliative chemotherapy in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC) who are not suitable for ...
Eldeeb Hany, Camileri Philip, Mak Choi
doaj   +1 more source

Pediatric Mediastinal Gray Zone Lymphoma With Germline TET2 Heterozygous Variant

open access: yes
Pediatric Blood &Cancer, EarlyView.
Matthew R. Schuelke   +9 more
wiley   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Use of radiobiological modeling in treatment plan evaluation and optimization of prostate cancer radiotherapy [PDF]

open access: yes, 2011
There are many tools available that are used to evaluate a radiotherapy treatment plan, such as isodose distribution charts, dose volume histograms (DVH), maximum, minimum and mean doses of the dose distributions as well as DVH point dose constraints ...
Baltas, Dimos   +8 more
core   +1 more source

Principle of Cancer Radiotherapy

open access: yes, 2021
Radiotherapy is one of the most common types of nonsurgical anticancer treatment modality, employed in more than 50% of cases. Almost half of cancer patients are cured of their cancer by radiotherapy as part of their anticancer treatment.
Lee, VHF, Lee, WMA
core   +1 more source

HDR and LDR Brachytherapy in the Treatment of Lip Cancer: the Experience of the Catalan Institute of Oncology

open access: yesJournal of Contemporary Brachytherapy, 2010
Purpose: Lip cancer can be treated by surgery, external radiotherapy, and/or brachytherapy (BT). In recent years,BT has become increasingly favored for this type of cancer.
Ferran Guedea   +4 more
doaj  

Home - About - Disclaimer - Privacy